| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |